ArticleRSC advances2022

Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope.

Tsung-Che Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.